A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA

Iatrogenic glucocorticoid (GC)-induced osteoporosis (GIO) is an idiosyncratic form of secondary osteoporosis. Genetic predisposition among individuals may give rise to variant degree of phenotypic changes but there has yet been a documented unified pathway to explain the idiosyncrasy. In this study,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li Lu, Yanzhen Cai, Xiaoling Luo, Zhangting Wang, Sin Hang Fung, Huanhuan Jia, Chi Lam Yu, Wai Yee Chan, Kai Kei Miu, Wende Xiao
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/6d2c8ea5b86f45f8b7047596e82833d9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6d2c8ea5b86f45f8b7047596e82833d9
record_format dspace
spelling oai:doaj.org-article:6d2c8ea5b86f45f8b7047596e82833d92021-11-30T16:27:05ZA Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA1663-981210.3389/fphar.2021.750959https://doaj.org/article/6d2c8ea5b86f45f8b7047596e82833d92021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.750959/fullhttps://doaj.org/toc/1663-9812Iatrogenic glucocorticoid (GC)-induced osteoporosis (GIO) is an idiosyncratic form of secondary osteoporosis. Genetic predisposition among individuals may give rise to variant degree of phenotypic changes but there has yet been a documented unified pathway to explain the idiosyncrasy. In this study, we argue that the susceptibility to epigenetic changes governing molecular cross talks along the BMP and PI3K/Akt pathway may underline how genetic background dictate GC-induced bone loss. Concordantly, osteoblasts from BALB/c or C57BL/6 neonatal mice were treated with dexamethasone for transcriptome profiling. Furthermore, we also confirmed that GC-pre-conditioned mesenchymal stem cells (MSCs) would give rise to defective osteogenesis by instigating epigenetic changes which affected the accessibility of enhancer marks. In line with these epigenetic changes, we propose that GC modulates a key regulatory network involving the scavenger receptor Cd36 in osteoblasts pre-conditioning pharmacological idiosyncrasy in GIO.Li LuYanzhen CaiXiaoling LuoZhangting WangSin Hang FungHuanhuan JiaHuanhuan JiaChi Lam YuWai Yee ChanKai Kei MiuWende XiaoFrontiers Media S.A.articleglucocorticoidglucocorticoid-induced osteoporosisbone lossbone morphogenetic protein signaling pathwayosteoblasts differentiationcis-expression quantitative trait lociTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic glucocorticoid
glucocorticoid-induced osteoporosis
bone loss
bone morphogenetic protein signaling pathway
osteoblasts differentiation
cis-expression quantitative trait loci
Therapeutics. Pharmacology
RM1-950
spellingShingle glucocorticoid
glucocorticoid-induced osteoporosis
bone loss
bone morphogenetic protein signaling pathway
osteoblasts differentiation
cis-expression quantitative trait loci
Therapeutics. Pharmacology
RM1-950
Li Lu
Yanzhen Cai
Xiaoling Luo
Zhangting Wang
Sin Hang Fung
Huanhuan Jia
Huanhuan Jia
Chi Lam Yu
Wai Yee Chan
Kai Kei Miu
Wende Xiao
A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA
description Iatrogenic glucocorticoid (GC)-induced osteoporosis (GIO) is an idiosyncratic form of secondary osteoporosis. Genetic predisposition among individuals may give rise to variant degree of phenotypic changes but there has yet been a documented unified pathway to explain the idiosyncrasy. In this study, we argue that the susceptibility to epigenetic changes governing molecular cross talks along the BMP and PI3K/Akt pathway may underline how genetic background dictate GC-induced bone loss. Concordantly, osteoblasts from BALB/c or C57BL/6 neonatal mice were treated with dexamethasone for transcriptome profiling. Furthermore, we also confirmed that GC-pre-conditioned mesenchymal stem cells (MSCs) would give rise to defective osteogenesis by instigating epigenetic changes which affected the accessibility of enhancer marks. In line with these epigenetic changes, we propose that GC modulates a key regulatory network involving the scavenger receptor Cd36 in osteoblasts pre-conditioning pharmacological idiosyncrasy in GIO.
format article
author Li Lu
Yanzhen Cai
Xiaoling Luo
Zhangting Wang
Sin Hang Fung
Huanhuan Jia
Huanhuan Jia
Chi Lam Yu
Wai Yee Chan
Kai Kei Miu
Wende Xiao
author_facet Li Lu
Yanzhen Cai
Xiaoling Luo
Zhangting Wang
Sin Hang Fung
Huanhuan Jia
Huanhuan Jia
Chi Lam Yu
Wai Yee Chan
Kai Kei Miu
Wende Xiao
author_sort Li Lu
title A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA
title_short A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA
title_full A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA
title_fullStr A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA
title_full_unstemmed A Core Omnigenic Non-coding Trait Governing Dex-Induced Osteoporotic Effects Identified Without DEXA
title_sort core omnigenic non-coding trait governing dex-induced osteoporotic effects identified without dexa
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/6d2c8ea5b86f45f8b7047596e82833d9
work_keys_str_mv AT lilu acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT yanzhencai acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT xiaolingluo acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT zhangtingwang acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT sinhangfung acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT huanhuanjia acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT huanhuanjia acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT chilamyu acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT waiyeechan acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT kaikeimiu acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT wendexiao acoreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT lilu coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT yanzhencai coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT xiaolingluo coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT zhangtingwang coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT sinhangfung coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT huanhuanjia coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT huanhuanjia coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT chilamyu coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT waiyeechan coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT kaikeimiu coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
AT wendexiao coreomnigenicnoncodingtraitgoverningdexinducedosteoporoticeffectsidentifiedwithoutdexa
_version_ 1718406448751312896